Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data.
Rath B, Gidudu JF, Anyoti H, Bollweg B, Caubel P, Chen YH, Cornblath D, Fernandopulle R, Fries L, Galama J, Gibbs N, Grilli G, Grogan P, Hartmann K, Heininger U, Hudson MJ, Izurieta HS, Jevaji I, Johnson WM, Jones J, Keller-Stanislawski B, Klein J, Kohl K, Kokotis P, Li Y, Linder T, Oleske J, Richard G, Shafshak T, Vajdy M, Wong V, Sejvar J; Brighton Collaboration Bell's Palsy Working Group. Rath B, et al. Among authors: fries l. Vaccine. 2017 Apr 4;35(15):1972-1983. doi: 10.1016/j.vaccine.2016.05.023. Epub 2016 May 24. Vaccine. 2017. PMID: 27235092 No abstract available.
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF 3rd, Glenn GM. Smith GE, et al. Vaccine. 2013 Sep 13;31(40):4305-13. doi: 10.1016/j.vaccine.2013.07.043. Epub 2013 Jul 26. Vaccine. 2013. PMID: 23891795 Free article.
ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
Chung KY, Coyle EM, Jani D, King LR, Bhardwaj R, Fries L, Smith G, Glenn G, Golding H, Khurana S. Chung KY, et al. Among authors: fries l. Vaccine. 2015 Jul 31;33(32):3953-62. doi: 10.1016/j.vaccine.2015.06.047. Epub 2015 Jun 17. Vaccine. 2015. PMID: 26093202 Clinical Trial.
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
August A, Glenn GM, Kpamegan E, Hickman SP, Jani D, Lu H, Thomas DN, Wen J, Piedra PA, Fries LF. August A, et al. Vaccine. 2017 Jun 27;35(30):3749-3759. doi: 10.1016/j.vaccine.2017.05.045. Epub 2017 Jun 1. Vaccine. 2017. PMID: 28579233 Free article. Clinical Trial.
Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group. Ampofo WK, et al. Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090. Epub 2015 Jul 3. Vaccine. 2015. PMID: 26148877 Free article.
178 results